Baili Tianheng's Iza‑bren (iza‑bren), the world's first and only approved EGFR×HER3 bispecific antibody‑drug conjugate (ADC), has been included in the 2026 National Basic Medical Insurance, Work-Related Injury and Maternity Insurance Drug Catalogue following national reimbursement negotiations. Benefiting from this year's new 'pre‑filing' mechanism, Iza‑bren achieved reimbursement inclusion in its first year on market.

US equities closed mixed on Friday: the Dow Jones rose 0.1%, the S&P 500 fell 0.4% and the Nasdaq Composite dropped 0.91%. AMD (AMD.O) fell 8.75%, Dell (DELL.N) declined 7.24%, CoreWeave (CRWV.O) -6.13%, SanDisk (SNDK.O) -5.59%, Broadcom (AVGO.O) -4.76%, SK Hynix ADR (SKHY.O) -4.3% and NVIDIA (NVDA.O) -2.01%; Meta Platforms (META.O) rose 2.9% and Microsoft (MSFT.O) gained 0.17%. The Nasdaq Golden Dragon China Index was up 0.84%; Baidu (BIDU.O) +0.66%, Alibaba (BABA.N) -0.02%.

美联储戴利：企业持谨慎乐观态度，但所有人都担心通胀。